tradmap

REVB Earnings REVELATION BIOSCIENCES, INC.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$1790 -$895 $0 2021 2022 2023 2024 2025
EPS
Net income (annual)
-$15M -$8M $0 2019 2020 2021 2022 2023 2024 2025
Net income
Return on equity (annual)
-1029% 5511% 12051% 0% 2019 2020 2021 2022 2023 2024 2025
ROE

Quarterly results

Diluted EPS (quarterly)
-$985 -$210 $566 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Net income (quarterly)
-$8M -$4M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-736% -368% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–25 of 25
Q2 20262026-06-30-0.872026-08-0610-Q
Q1 20262026-03-31-2.712026-05-0710-Q
Q4 2025 (derived)2025-12-3136.512026-02-2610-K
FY 20252025-12-31-23.952026-02-2610-K
Q3 20252025-09-30-7.082025-11-0610-Q
Q2 20252025-06-30-28.042025-08-0810-Q
Q1 20252025-03-31-25.342025-05-0810-Q
Q4 2024 (derived)2024-12-31565.962025-03-0610-K
FY 20242024-12-31-1052.162025-03-0610-K
Q3 20242024-09-30-160.602024-11-0810-Q
Q2 20242024-06-30-985.082024-08-0910-Q
Q1 20242024-03-31-472.442024-05-1010-Q
Q4 2023 (derived)2023-12-31-483.042024-03-2210-K
FY 20232023-12-31-101.282024-03-2210-K
Q3 20232023-09-30-39.762023-11-0910-Q
Q2 20232023-06-30-23.322023-08-1110-Q
Q1 20232023-03-31444.842023-05-2210-Q
Q4 2022 (derived)2022-12-31-1575.322023-03-3010-K
FY 20222022-12-31-1790.402023-03-3010-K
Q3 20222022-09-30-7.642022-11-1010-Q
Q2 20222022-06-30-16.642022-08-1510-Q
Q1 20222022-03-31-190.80——
FY 20212021-12-31-510.00——
Q3 20212021-09-30-5.76——
Q2 20212021-06-30-4.68——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.